Lumos Pharma

About:

Lumos Pharma is a biopharmaceutical company that develops a novel treatment for the rare disease Creatine Transporter Deficiency.

Website: http://lumos-pharma.com

Twitter/X: lumos_pharma

Top Investors: Deerfield, New Enterprise Associates, Sante Ventures, Roche Venture Fund, Clarus Ventures

Description:

Lumos Pharma, based in Austin, Texas, is an early-stage biotechnology company created to develop and commercialize a novel treatment for the rare disease Creatine Transporter Deficiency. Lumos Pharma is the exclusive licensee of technology and discoveries made in laboratories at the University of Cincinnati and has partnered with Key Opinion Leaders in the field and the United States National Institutes of Health to ensure success in developing a treatment for Creatine Transporter Deficiency. It was founded in 2014 and is headquartered in Austin, Texas.